Global Oncolytic Virus Service Market Research Report 2024(Status and Outlook)
Report Overview
The main contents of oncolytic virus services include virus screening, virus production, quality testing, drug efficacy evaluation, etc. In this process, pharmaceutical companies can select different virus strains and, after appropriate genetic engineering, be used to treat different types of tumors.
The global Oncolytic Virus Service market size was estimated at USD 64250 million in 2023 and is projected to reach USD 241180.21 million by 2030, exhibiting a CAGR of 20.80% during the forecast period.
North America Oncolytic Virus Service market size was USD 16741.71 million in 2023, at a CAGR of 17.83% during the forecast period of 2024 through 2030.
This report provides a deep insight into the global Oncolytic Virus Service market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oncolytic Virus Service Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oncolytic Virus Service market in any manner.
Global Oncolytic Virus Service Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Creative Biolabs
Creative Biogene
Recipharm
Nabios
IDT Biologika
FUJIFILM Diosynth Biotechnologies
Exothera
Lonza
ABL
Takara Bio
Libentech
Market Segmentation (by Type)
Measles Virus (MeV)
Herpes Simplex Virus (HSV-1)
Others
Market Segmentation (by Application)
Tumor Treatment
Scientific Research
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncolytic Virus Service Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 12 is the main points and conclusions of the report.
The main contents of oncolytic virus services include virus screening, virus production, quality testing, drug efficacy evaluation, etc. In this process, pharmaceutical companies can select different virus strains and, after appropriate genetic engineering, be used to treat different types of tumors.
The global Oncolytic Virus Service market size was estimated at USD 64250 million in 2023 and is projected to reach USD 241180.21 million by 2030, exhibiting a CAGR of 20.80% during the forecast period.
North America Oncolytic Virus Service market size was USD 16741.71 million in 2023, at a CAGR of 17.83% during the forecast period of 2024 through 2030.
This report provides a deep insight into the global Oncolytic Virus Service market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oncolytic Virus Service Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oncolytic Virus Service market in any manner.
Global Oncolytic Virus Service Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Creative Biolabs
Creative Biogene
Recipharm
Nabios
IDT Biologika
FUJIFILM Diosynth Biotechnologies
Exothera
Lonza
ABL
Takara Bio
Libentech
Market Segmentation (by Type)
Measles Virus (MeV)
Herpes Simplex Virus (HSV-1)
Others
Market Segmentation (by Application)
Tumor Treatment
Scientific Research
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Oncolytic Virus Service Market
- Overview of the regional outlook of the Oncolytic Virus Service Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncolytic Virus Service Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Oncolytic Virus Service
1.2 Key Market Segments
1.2.1 Oncolytic Virus Service Segment by Type
1.2.2 Oncolytic Virus Service Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONCOLYTIC VIRUS SERVICE MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONCOLYTIC VIRUS SERVICE MARKET COMPETITIVE LANDSCAPE
3.1 Global Oncolytic Virus Service Revenue Market Share by Company (2019-2024)
3.2 Oncolytic Virus Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Oncolytic Virus Service Market Size Sites, Area Served, Product Type
3.4 Oncolytic Virus Service Market Competitive Situation and Trends
3.4.1 Oncolytic Virus Service Market Concentration Rate
3.4.2 Global 5 and 10 Largest Oncolytic Virus Service Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 ONCOLYTIC VIRUS SERVICE VALUE CHAIN ANALYSIS
4.1 Oncolytic Virus Service Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONCOLYTIC VIRUS SERVICE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 ONCOLYTIC VIRUS SERVICE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncolytic Virus Service Market Size Market Share by Type (2019-2024)
6.3 Global Oncolytic Virus Service Market Size Growth Rate by Type (2019-2024)
7 ONCOLYTIC VIRUS SERVICE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncolytic Virus Service Market Size (M USD) by Application (2019-2024)
7.3 Global Oncolytic Virus Service Market Size Growth Rate by Application (2019-2024)
8 ONCOLYTIC VIRUS SERVICE MARKET SEGMENTATION BY REGION
8.1 Global Oncolytic Virus Service Market Size by Region
8.1.1 Global Oncolytic Virus Service Market Size by Region
8.1.2 Global Oncolytic Virus Service Market Size Market Share by Region
8.2 North America
8.2.1 North America Oncolytic Virus Service Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oncolytic Virus Service Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oncolytic Virus Service Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oncolytic Virus Service Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oncolytic Virus Service Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Creative Biolabs
9.1.1 Creative Biolabs Oncolytic Virus Service Basic Information
9.1.2 Creative Biolabs Oncolytic Virus Service Product Overview
9.1.3 Creative Biolabs Oncolytic Virus Service Product Market Performance
9.1.4 Creative Biolabs Oncolytic Virus Service SWOT Analysis
9.1.5 Creative Biolabs Business Overview
9.1.6 Creative Biolabs Recent Developments
9.2 Creative Biogene
9.2.1 Creative Biogene Oncolytic Virus Service Basic Information
9.2.2 Creative Biogene Oncolytic Virus Service Product Overview
9.2.3 Creative Biogene Oncolytic Virus Service Product Market Performance
9.2.4 Creative Biogene Oncolytic Virus Service SWOT Analysis
9.2.5 Creative Biogene Business Overview
9.2.6 Creative Biogene Recent Developments
9.3 Recipharm
9.3.1 Recipharm Oncolytic Virus Service Basic Information
9.3.2 Recipharm Oncolytic Virus Service Product Overview
9.3.3 Recipharm Oncolytic Virus Service Product Market Performance
9.3.4 Recipharm Oncolytic Virus Service SWOT Analysis
9.3.5 Recipharm Business Overview
9.3.6 Recipharm Recent Developments
9.4 Nabios
9.4.1 Nabios Oncolytic Virus Service Basic Information
9.4.2 Nabios Oncolytic Virus Service Product Overview
9.4.3 Nabios Oncolytic Virus Service Product Market Performance
9.4.4 Nabios Business Overview
9.4.5 Nabios Recent Developments
9.5 IDT Biologika
9.5.1 IDT Biologika Oncolytic Virus Service Basic Information
9.5.2 IDT Biologika Oncolytic Virus Service Product Overview
9.5.3 IDT Biologika Oncolytic Virus Service Product Market Performance
9.5.4 IDT Biologika Business Overview
9.5.5 IDT Biologika Recent Developments
9.6 FUJIFILM Diosynth Biotechnologies
9.6.1 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Basic Information
9.6.2 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Product Overview
9.6.3 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Product Market Performance
9.6.4 FUJIFILM Diosynth Biotechnologies Business Overview
9.6.5 FUJIFILM Diosynth Biotechnologies Recent Developments
9.7 Exothera
9.7.1 Exothera Oncolytic Virus Service Basic Information
9.7.2 Exothera Oncolytic Virus Service Product Overview
9.7.3 Exothera Oncolytic Virus Service Product Market Performance
9.7.4 Exothera Business Overview
9.7.5 Exothera Recent Developments
9.8 Lonza
9.8.1 Lonza Oncolytic Virus Service Basic Information
9.8.2 Lonza Oncolytic Virus Service Product Overview
9.8.3 Lonza Oncolytic Virus Service Product Market Performance
9.8.4 Lonza Business Overview
9.8.5 Lonza Recent Developments
9.9 ABL
9.9.1 ABL Oncolytic Virus Service Basic Information
9.9.2 ABL Oncolytic Virus Service Product Overview
9.9.3 ABL Oncolytic Virus Service Product Market Performance
9.9.4 ABL Business Overview
9.9.5 ABL Recent Developments
9.10 Takara Bio
9.10.1 Takara Bio Oncolytic Virus Service Basic Information
9.10.2 Takara Bio Oncolytic Virus Service Product Overview
9.10.3 Takara Bio Oncolytic Virus Service Product Market Performance
9.10.4 Takara Bio Business Overview
9.10.5 Takara Bio Recent Developments
9.11 Libentech
9.11.1 Libentech Oncolytic Virus Service Basic Information
9.11.2 Libentech Oncolytic Virus Service Product Overview
9.11.3 Libentech Oncolytic Virus Service Product Market Performance
9.11.4 Libentech Business Overview
9.11.5 Libentech Recent Developments
10 ONCOLYTIC VIRUS SERVICE REGIONAL MARKET FORECAST
10.1 Global Oncolytic Virus Service Market Size Forecast
10.2 Global Oncolytic Virus Service Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oncolytic Virus Service Market Size Forecast by Country
10.2.3 Asia Pacific Oncolytic Virus Service Market Size Forecast by Region
10.2.4 South America Oncolytic Virus Service Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oncolytic Virus Service by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Oncolytic Virus Service Market Forecast by Type (2025-2030)
11.2 Global Oncolytic Virus Service Market Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Oncolytic Virus Service
1.2 Key Market Segments
1.2.1 Oncolytic Virus Service Segment by Type
1.2.2 Oncolytic Virus Service Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONCOLYTIC VIRUS SERVICE MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONCOLYTIC VIRUS SERVICE MARKET COMPETITIVE LANDSCAPE
3.1 Global Oncolytic Virus Service Revenue Market Share by Company (2019-2024)
3.2 Oncolytic Virus Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Oncolytic Virus Service Market Size Sites, Area Served, Product Type
3.4 Oncolytic Virus Service Market Competitive Situation and Trends
3.4.1 Oncolytic Virus Service Market Concentration Rate
3.4.2 Global 5 and 10 Largest Oncolytic Virus Service Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 ONCOLYTIC VIRUS SERVICE VALUE CHAIN ANALYSIS
4.1 Oncolytic Virus Service Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONCOLYTIC VIRUS SERVICE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 ONCOLYTIC VIRUS SERVICE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncolytic Virus Service Market Size Market Share by Type (2019-2024)
6.3 Global Oncolytic Virus Service Market Size Growth Rate by Type (2019-2024)
7 ONCOLYTIC VIRUS SERVICE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncolytic Virus Service Market Size (M USD) by Application (2019-2024)
7.3 Global Oncolytic Virus Service Market Size Growth Rate by Application (2019-2024)
8 ONCOLYTIC VIRUS SERVICE MARKET SEGMENTATION BY REGION
8.1 Global Oncolytic Virus Service Market Size by Region
8.1.1 Global Oncolytic Virus Service Market Size by Region
8.1.2 Global Oncolytic Virus Service Market Size Market Share by Region
8.2 North America
8.2.1 North America Oncolytic Virus Service Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oncolytic Virus Service Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oncolytic Virus Service Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oncolytic Virus Service Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oncolytic Virus Service Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Creative Biolabs
9.1.1 Creative Biolabs Oncolytic Virus Service Basic Information
9.1.2 Creative Biolabs Oncolytic Virus Service Product Overview
9.1.3 Creative Biolabs Oncolytic Virus Service Product Market Performance
9.1.4 Creative Biolabs Oncolytic Virus Service SWOT Analysis
9.1.5 Creative Biolabs Business Overview
9.1.6 Creative Biolabs Recent Developments
9.2 Creative Biogene
9.2.1 Creative Biogene Oncolytic Virus Service Basic Information
9.2.2 Creative Biogene Oncolytic Virus Service Product Overview
9.2.3 Creative Biogene Oncolytic Virus Service Product Market Performance
9.2.4 Creative Biogene Oncolytic Virus Service SWOT Analysis
9.2.5 Creative Biogene Business Overview
9.2.6 Creative Biogene Recent Developments
9.3 Recipharm
9.3.1 Recipharm Oncolytic Virus Service Basic Information
9.3.2 Recipharm Oncolytic Virus Service Product Overview
9.3.3 Recipharm Oncolytic Virus Service Product Market Performance
9.3.4 Recipharm Oncolytic Virus Service SWOT Analysis
9.3.5 Recipharm Business Overview
9.3.6 Recipharm Recent Developments
9.4 Nabios
9.4.1 Nabios Oncolytic Virus Service Basic Information
9.4.2 Nabios Oncolytic Virus Service Product Overview
9.4.3 Nabios Oncolytic Virus Service Product Market Performance
9.4.4 Nabios Business Overview
9.4.5 Nabios Recent Developments
9.5 IDT Biologika
9.5.1 IDT Biologika Oncolytic Virus Service Basic Information
9.5.2 IDT Biologika Oncolytic Virus Service Product Overview
9.5.3 IDT Biologika Oncolytic Virus Service Product Market Performance
9.5.4 IDT Biologika Business Overview
9.5.5 IDT Biologika Recent Developments
9.6 FUJIFILM Diosynth Biotechnologies
9.6.1 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Basic Information
9.6.2 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Product Overview
9.6.3 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Product Market Performance
9.6.4 FUJIFILM Diosynth Biotechnologies Business Overview
9.6.5 FUJIFILM Diosynth Biotechnologies Recent Developments
9.7 Exothera
9.7.1 Exothera Oncolytic Virus Service Basic Information
9.7.2 Exothera Oncolytic Virus Service Product Overview
9.7.3 Exothera Oncolytic Virus Service Product Market Performance
9.7.4 Exothera Business Overview
9.7.5 Exothera Recent Developments
9.8 Lonza
9.8.1 Lonza Oncolytic Virus Service Basic Information
9.8.2 Lonza Oncolytic Virus Service Product Overview
9.8.3 Lonza Oncolytic Virus Service Product Market Performance
9.8.4 Lonza Business Overview
9.8.5 Lonza Recent Developments
9.9 ABL
9.9.1 ABL Oncolytic Virus Service Basic Information
9.9.2 ABL Oncolytic Virus Service Product Overview
9.9.3 ABL Oncolytic Virus Service Product Market Performance
9.9.4 ABL Business Overview
9.9.5 ABL Recent Developments
9.10 Takara Bio
9.10.1 Takara Bio Oncolytic Virus Service Basic Information
9.10.2 Takara Bio Oncolytic Virus Service Product Overview
9.10.3 Takara Bio Oncolytic Virus Service Product Market Performance
9.10.4 Takara Bio Business Overview
9.10.5 Takara Bio Recent Developments
9.11 Libentech
9.11.1 Libentech Oncolytic Virus Service Basic Information
9.11.2 Libentech Oncolytic Virus Service Product Overview
9.11.3 Libentech Oncolytic Virus Service Product Market Performance
9.11.4 Libentech Business Overview
9.11.5 Libentech Recent Developments
10 ONCOLYTIC VIRUS SERVICE REGIONAL MARKET FORECAST
10.1 Global Oncolytic Virus Service Market Size Forecast
10.2 Global Oncolytic Virus Service Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oncolytic Virus Service Market Size Forecast by Country
10.2.3 Asia Pacific Oncolytic Virus Service Market Size Forecast by Region
10.2.4 South America Oncolytic Virus Service Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oncolytic Virus Service by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Oncolytic Virus Service Market Forecast by Type (2025-2030)
11.2 Global Oncolytic Virus Service Market Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Oncolytic Virus Service Market Size Comparison by Region (M USD)
Table 5. Global Oncolytic Virus Service Revenue (M USD) by Company (2019-2024)
Table 6. Global Oncolytic Virus Service Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Service as of 2022)
Table 8. Company Oncolytic Virus Service Market Size Sites and Area Served
Table 9. Company Oncolytic Virus Service Product Type
Table 10. Global Oncolytic Virus Service Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Oncolytic Virus Service
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Oncolytic Virus Service Market Challenges
Table 18. Global Oncolytic Virus Service Market Size by Type (M USD)
Table 19. Global Oncolytic Virus Service Market Size (M USD) by Type (2019-2024)
Table 20. Global Oncolytic Virus Service Market Size Share by Type (2019-2024)
Table 21. Global Oncolytic Virus Service Market Size Growth Rate by Type (2019-2024)
Table 22. Global Oncolytic Virus Service Market Size by Application
Table 23. Global Oncolytic Virus Service Market Size by Application (2019-2024) & (M USD)
Table 24. Global Oncolytic Virus Service Market Share by Application (2019-2024)
Table 25. Global Oncolytic Virus Service Market Size Growth Rate by Application (2019-2024)
Table 26. Global Oncolytic Virus Service Market Size by Region (2019-2024) & (M USD)
Table 27. Global Oncolytic Virus Service Market Size Market Share by Region (2019-2024)
Table 28. North America Oncolytic Virus Service Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Oncolytic Virus Service Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Oncolytic Virus Service Market Size by Region (2019-2024) & (M USD)
Table 31. South America Oncolytic Virus Service Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Oncolytic Virus Service Market Size by Region (2019-2024) & (M USD)
Table 33. Creative Biolabs Oncolytic Virus Service Basic Information
Table 34. Creative Biolabs Oncolytic Virus Service Product Overview
Table 35. Creative Biolabs Oncolytic Virus Service Revenue (M USD) and Gross Margin (2019-2024)
Table 36. Creative Biolabs Oncolytic Virus Service SWOT Analysis
Table 37. Creative Biolabs Business Overview
Table 38. Creative Biolabs Recent Developments
Table 39. Creative Biogene Oncolytic Virus Service Basic Information
Table 40. Creative Biogene Oncolytic Virus Service Product Overview
Table 41. Creative Biogene Oncolytic Virus Service Revenue (M USD) and Gross Margin (2019-2024)
Table 42. Creative Biogene Oncolytic Virus Service SWOT Analysis
Table 43. Creative Biogene Business Overview
Table 44. Creative Biogene Recent Developments
Table 45. Recipharm Oncolytic Virus Service Basic Information
Table 46. Recipharm Oncolytic Virus Service Product Overview
Table 47. Recipharm Oncolytic Virus Service Revenue (M USD) and Gross Margin (2019-2024)
Table 48. Recipharm Oncolytic Virus Service SWOT Analysis
Table 49. Recipharm Business Overview
Table 50. Recipharm Recent Developments
Table 51. Nabios Oncolytic Virus Service Basic Information
Table 52. Nabios Oncolytic Virus Service Product Overview
Table 53. Nabios Oncolytic Virus Service Revenue (M USD) and Gross Margin (2019-2024)
Table 54. Nabios Business Overview
Table 55. Nabios Recent Developments
Table 56. IDT Biologika Oncolytic Virus Service Basic Information
Table 57. IDT Biologika Oncolytic Virus Service Product Overview
Table 58. IDT Biologika Oncolytic Virus Service Revenue (M USD) and Gross Margin (2019-2024)
Table 59. IDT Biologika Business Overview
Table 60. IDT Biologika Recent Developments
Table 61. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Basic Information
Table 62. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Product Overview
Table 63. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Revenue (M USD) and Gross Margin (2019-2024)
Table 64. FUJIFILM Diosynth Biotechnologies Business Overview
Table 65. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 66. Exothera Oncolytic Virus Service Basic Information
Table 67. Exothera Oncolytic Virus Service Product Overview
Table 68. Exothera Oncolytic Virus Service Revenue (M USD) and Gross Margin (2019-2024)
Table 69. Exothera Business Overview
Table 70. Exothera Recent Developments
Table 71. Lonza Oncolytic Virus Service Basic Information
Table 72. Lonza Oncolytic Virus Service Product Overview
Table 73. Lonza Oncolytic Virus Service Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Lonza Business Overview
Table 75. Lonza Recent Developments
Table 76. ABL Oncolytic Virus Service Basic Information
Table 77. ABL Oncolytic Virus Service Product Overview
Table 78. ABL Oncolytic Virus Service Revenue (M USD) and Gross Margin (2019-2024)
Table 79. ABL Business Overview
Table 80. ABL Recent Developments
Table 81. Takara Bio Oncolytic Virus Service Basic Information
Table 82. Takara Bio Oncolytic Virus Service Product Overview
Table 83. Takara Bio Oncolytic Virus Service Revenue (M USD) and Gross Margin (2019-2024)
Table 84. Takara Bio Business Overview
Table 85. Takara Bio Recent Developments
Table 86. Libentech Oncolytic Virus Service Basic Information
Table 87. Libentech Oncolytic Virus Service Product Overview
Table 88. Libentech Oncolytic Virus Service Revenue (M USD) and Gross Margin (2019-2024)
Table 89. Libentech Business Overview
Table 90. Libentech Recent Developments
Table 91. Global Oncolytic Virus Service Market Size Forecast by Region (2025-2030) & (M USD)
Table 92. North America Oncolytic Virus Service Market Size Forecast by Country (2025-2030) & (M USD)
Table 93. Europe Oncolytic Virus Service Market Size Forecast by Country (2025-2030) & (M USD)
Table 94. Asia Pacific Oncolytic Virus Service Market Size Forecast by Region (2025-2030) & (M USD)
Table 95. South America Oncolytic Virus Service Market Size Forecast by Country (2025-2030) & (M USD)
Table 96. Middle East and Africa Oncolytic Virus Service Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Global Oncolytic Virus Service Market Size Forecast by Type (2025-2030) & (M USD)
Table 98. Global Oncolytic Virus Service Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Oncolytic Virus Service Market Size Comparison by Region (M USD)
Table 5. Global Oncolytic Virus Service Revenue (M USD) by Company (2019-2024)
Table 6. Global Oncolytic Virus Service Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Service as of 2022)
Table 8. Company Oncolytic Virus Service Market Size Sites and Area Served
Table 9. Company Oncolytic Virus Service Product Type
Table 10. Global Oncolytic Virus Service Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Oncolytic Virus Service
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Oncolytic Virus Service Market Challenges
Table 18. Global Oncolytic Virus Service Market Size by Type (M USD)
Table 19. Global Oncolytic Virus Service Market Size (M USD) by Type (2019-2024)
Table 20. Global Oncolytic Virus Service Market Size Share by Type (2019-2024)
Table 21. Global Oncolytic Virus Service Market Size Growth Rate by Type (2019-2024)
Table 22. Global Oncolytic Virus Service Market Size by Application
Table 23. Global Oncolytic Virus Service Market Size by Application (2019-2024) & (M USD)
Table 24. Global Oncolytic Virus Service Market Share by Application (2019-2024)
Table 25. Global Oncolytic Virus Service Market Size Growth Rate by Application (2019-2024)
Table 26. Global Oncolytic Virus Service Market Size by Region (2019-2024) & (M USD)
Table 27. Global Oncolytic Virus Service Market Size Market Share by Region (2019-2024)
Table 28. North America Oncolytic Virus Service Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Oncolytic Virus Service Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Oncolytic Virus Service Market Size by Region (2019-2024) & (M USD)
Table 31. South America Oncolytic Virus Service Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Oncolytic Virus Service Market Size by Region (2019-2024) & (M USD)
Table 33. Creative Biolabs Oncolytic Virus Service Basic Information
Table 34. Creative Biolabs Oncolytic Virus Service Product Overview
Table 35. Creative Biolabs Oncolytic Virus Service Revenue (M USD) and Gross Margin (2019-2024)
Table 36. Creative Biolabs Oncolytic Virus Service SWOT Analysis
Table 37. Creative Biolabs Business Overview
Table 38. Creative Biolabs Recent Developments
Table 39. Creative Biogene Oncolytic Virus Service Basic Information
Table 40. Creative Biogene Oncolytic Virus Service Product Overview
Table 41. Creative Biogene Oncolytic Virus Service Revenue (M USD) and Gross Margin (2019-2024)
Table 42. Creative Biogene Oncolytic Virus Service SWOT Analysis
Table 43. Creative Biogene Business Overview
Table 44. Creative Biogene Recent Developments
Table 45. Recipharm Oncolytic Virus Service Basic Information
Table 46. Recipharm Oncolytic Virus Service Product Overview
Table 47. Recipharm Oncolytic Virus Service Revenue (M USD) and Gross Margin (2019-2024)
Table 48. Recipharm Oncolytic Virus Service SWOT Analysis
Table 49. Recipharm Business Overview
Table 50. Recipharm Recent Developments
Table 51. Nabios Oncolytic Virus Service Basic Information
Table 52. Nabios Oncolytic Virus Service Product Overview
Table 53. Nabios Oncolytic Virus Service Revenue (M USD) and Gross Margin (2019-2024)
Table 54. Nabios Business Overview
Table 55. Nabios Recent Developments
Table 56. IDT Biologika Oncolytic Virus Service Basic Information
Table 57. IDT Biologika Oncolytic Virus Service Product Overview
Table 58. IDT Biologika Oncolytic Virus Service Revenue (M USD) and Gross Margin (2019-2024)
Table 59. IDT Biologika Business Overview
Table 60. IDT Biologika Recent Developments
Table 61. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Basic Information
Table 62. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Product Overview
Table 63. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Revenue (M USD) and Gross Margin (2019-2024)
Table 64. FUJIFILM Diosynth Biotechnologies Business Overview
Table 65. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 66. Exothera Oncolytic Virus Service Basic Information
Table 67. Exothera Oncolytic Virus Service Product Overview
Table 68. Exothera Oncolytic Virus Service Revenue (M USD) and Gross Margin (2019-2024)
Table 69. Exothera Business Overview
Table 70. Exothera Recent Developments
Table 71. Lonza Oncolytic Virus Service Basic Information
Table 72. Lonza Oncolytic Virus Service Product Overview
Table 73. Lonza Oncolytic Virus Service Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Lonza Business Overview
Table 75. Lonza Recent Developments
Table 76. ABL Oncolytic Virus Service Basic Information
Table 77. ABL Oncolytic Virus Service Product Overview
Table 78. ABL Oncolytic Virus Service Revenue (M USD) and Gross Margin (2019-2024)
Table 79. ABL Business Overview
Table 80. ABL Recent Developments
Table 81. Takara Bio Oncolytic Virus Service Basic Information
Table 82. Takara Bio Oncolytic Virus Service Product Overview
Table 83. Takara Bio Oncolytic Virus Service Revenue (M USD) and Gross Margin (2019-2024)
Table 84. Takara Bio Business Overview
Table 85. Takara Bio Recent Developments
Table 86. Libentech Oncolytic Virus Service Basic Information
Table 87. Libentech Oncolytic Virus Service Product Overview
Table 88. Libentech Oncolytic Virus Service Revenue (M USD) and Gross Margin (2019-2024)
Table 89. Libentech Business Overview
Table 90. Libentech Recent Developments
Table 91. Global Oncolytic Virus Service Market Size Forecast by Region (2025-2030) & (M USD)
Table 92. North America Oncolytic Virus Service Market Size Forecast by Country (2025-2030) & (M USD)
Table 93. Europe Oncolytic Virus Service Market Size Forecast by Country (2025-2030) & (M USD)
Table 94. Asia Pacific Oncolytic Virus Service Market Size Forecast by Region (2025-2030) & (M USD)
Table 95. South America Oncolytic Virus Service Market Size Forecast by Country (2025-2030) & (M USD)
Table 96. Middle East and Africa Oncolytic Virus Service Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Global Oncolytic Virus Service Market Size Forecast by Type (2025-2030) & (M USD)
Table 98. Global Oncolytic Virus Service Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Industrial Chain of Oncolytic Virus Service
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oncolytic Virus Service Market Size (M USD), 2019-2030
Figure 5. Global Oncolytic Virus Service Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Oncolytic Virus Service Market Size by Country (M USD)
Figure 10. Global Oncolytic Virus Service Revenue Share by Company in 2023
Figure 11. Oncolytic Virus Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Oncolytic Virus Service Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Oncolytic Virus Service Market Share by Type
Figure 15. Market Size Share of Oncolytic Virus Service by Type (2019-2024)
Figure 16. Market Size Market Share of Oncolytic Virus Service by Type in 2022
Figure 17. Global Oncolytic Virus Service Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Oncolytic Virus Service Market Share by Application
Figure 20. Global Oncolytic Virus Service Market Share by Application (2019-2024)
Figure 21. Global Oncolytic Virus Service Market Share by Application in 2022
Figure 22. Global Oncolytic Virus Service Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Oncolytic Virus Service Market Size Market Share by Region (2019-2024)
Figure 24. North America Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Oncolytic Virus Service Market Size Market Share by Country in 2023
Figure 26. U.S. Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Oncolytic Virus Service Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Oncolytic Virus Service Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Oncolytic Virus Service Market Size Market Share by Country in 2023
Figure 31. Germany Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Oncolytic Virus Service Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Oncolytic Virus Service Market Size Market Share by Region in 2023
Figure 38. China Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Oncolytic Virus Service Market Size and Growth Rate (M USD)
Figure 44. South America Oncolytic Virus Service Market Size Market Share by Country in 2023
Figure 45. Brazil Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Oncolytic Virus Service Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Oncolytic Virus Service Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Oncolytic Virus Service Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Oncolytic Virus Service Market Share Forecast by Type (2025-2030)
Figure 57. Global Oncolytic Virus Service Market Share Forecast by Application (2025-2030)
Figure 1. Industrial Chain of Oncolytic Virus Service
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oncolytic Virus Service Market Size (M USD), 2019-2030
Figure 5. Global Oncolytic Virus Service Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Oncolytic Virus Service Market Size by Country (M USD)
Figure 10. Global Oncolytic Virus Service Revenue Share by Company in 2023
Figure 11. Oncolytic Virus Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Oncolytic Virus Service Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Oncolytic Virus Service Market Share by Type
Figure 15. Market Size Share of Oncolytic Virus Service by Type (2019-2024)
Figure 16. Market Size Market Share of Oncolytic Virus Service by Type in 2022
Figure 17. Global Oncolytic Virus Service Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Oncolytic Virus Service Market Share by Application
Figure 20. Global Oncolytic Virus Service Market Share by Application (2019-2024)
Figure 21. Global Oncolytic Virus Service Market Share by Application in 2022
Figure 22. Global Oncolytic Virus Service Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Oncolytic Virus Service Market Size Market Share by Region (2019-2024)
Figure 24. North America Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Oncolytic Virus Service Market Size Market Share by Country in 2023
Figure 26. U.S. Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Oncolytic Virus Service Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Oncolytic Virus Service Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Oncolytic Virus Service Market Size Market Share by Country in 2023
Figure 31. Germany Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Oncolytic Virus Service Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Oncolytic Virus Service Market Size Market Share by Region in 2023
Figure 38. China Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Oncolytic Virus Service Market Size and Growth Rate (M USD)
Figure 44. South America Oncolytic Virus Service Market Size Market Share by Country in 2023
Figure 45. Brazil Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Oncolytic Virus Service Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Oncolytic Virus Service Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Oncolytic Virus Service Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Oncolytic Virus Service Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Oncolytic Virus Service Market Share Forecast by Type (2025-2030)
Figure 57. Global Oncolytic Virus Service Market Share Forecast by Application (2025-2030)
